GESTIÓN EN SALUD PÚBLICA: Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification Guidance for Industry | FDA

viernes, 4 de junio de 2021

Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification Guidance for Industry | FDA

Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification Guidance for Industry | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)